We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aspiration of Residual Gastric Contents

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01863043
First Posted: May 27, 2013
Last Update Posted: February 8, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute of Nursing Research (NINR)
Information provided by (Responsible Party):
University of Florida
  Purpose
The primary purpose of this study is to determine nutrition outcomes and risks to gastrointestinal integrity and function of aspirating for routine gastric contents prior to each feeding in very low birth weight premature infants.

Condition Intervention
Infant, Premature Nutrition, Enteral Procedure: No aspiration of gastric contents Procedure: Routine aspiration of gastric contents

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Routine Aspiration of Residual Gastric Contents in Very Low Birth Weight Infants

Resource links provided by NLM:


Further study details as provided by University of Florida:

Primary Outcome Measures:
  • 24-hour enteral feeding intake in mL/kg [ Time Frame: baseline to 6 weeks ]

Secondary Outcome Measures:
  • Time to reach full feeds [ Time Frame: baseline to approximately 3 weeks ]
    Full feeds is defined as 120 milliliters per kilogram per day

  • Hours receiving parenteral nutrition [ Time Frame: Baseline to 6 weeks ]
  • Weekly or biweekly liver function tests [ Time Frame: baseline to 6 weeks ]
    level of direct bilirubin, alkaline phosphatase aspartate aminotransferase and alanine aminotransferase

  • Hours of central venous line access [ Time Frame: Baseline to 6 weeks ]
  • Episodes of late onset sepsis [ Time Frame: baseline to 6 weeks ]
  • Growth indices [ Time Frame: baselines to 6 weeks ]
    Weight, length, and head circumference

  • Length of hospital stay [ Time Frame: baseline to approximately 3 months ]
    Days infant remains in hospital

  • Episodes of necrotizing enterocolitis [ Time Frame: Baseline to 6 weeks ]
    Episodes of radiologic evidence of necrotizing enterocolitis

  • Presence of blood in stools [ Time Frame: baseline to 6 weeks ]
    Positive or negative guaiac of all stools

  • Level of fecal calprotectin [ Time Frame: 3 and 6 weeks ]
  • serum gastrin level [ Time Frame: baseline to 21 days ]
  • motilin level [ Time Frame: baseline to 21 days ]
  • tracheal pepsin levels [ Time Frame: baseline to 35 days ]
  • presence of aspiration pneumonia [ Time Frame: baseline to 6 weeks ]
  • presence of ventilator associated pneumonia [ Time Frame: baseline to 6 weeks ]

Enrollment: 146
Actual Study Start Date: August 20, 2013
Estimated Study Completion Date: December 2017
Primary Completion Date: January 26, 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Routine aspiration of gastric contents
Infants will have routine aspiration of gastric contents prior to each feeding to monitor the amount of residual gastric contents remaining in the stomach.
Procedure: Routine aspiration of gastric contents
Infants will have routine aspiration of gastric contents prior to each feeding to monitor the amount of residual gastric contents remaining in the stomach.
Experimental: No aspiration of gastric contents
Infants will not have routine aspiration of gastric contents prior to every feeding to assess residual gastric contents.
Procedure: No aspiration of gastric contents
Infants will not have routine aspiration of gastric contents prior to every feeding to assess residual gastric contents.

Detailed Description:
The participants in the study will be randomly assigned (like the flip of a coin) to either have the leftover food in their stomach removed before each feeding, or not have the leftover food removed before each feeding. In addition, when a blood drawn is performed as regular care an extra amount with be taken. A test to determine how much of the hormones gastrin and motilin are contained in the blood will be performed. Stool samples will be collected. Participation could last up to approximately 6 to 8 weeks of age.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 3 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • born at 32 weeks of less of gestational age
  • birth weight </= to 1250 grams
  • receiving some enteral feedings by 72 hours of age
  • receiving parenteral feedings by 24 hours of age

Exclusion Criteria:

  • Congenital or chromosomal abnormalities
  • complex congenital heart diseases and congenital anatomic gastrointestinal abnormalities
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01863043


Locations
United States, Florida
Neonatal intensive care unit at Shands children's hospital at the Univeristy of Florida
Gainesville, Florida, United States, 32504
Sponsors and Collaborators
University of Florida
National Institute of Nursing Research (NINR)
Investigators
Principal Investigator: Leslie A Parker, PhD University of Florida
  More Information

Responsible Party: University of Florida
ClinicalTrials.gov Identifier: NCT01863043     History of Changes
Other Study ID Numbers: IRB201501174- N
1R01NR014019-01A1 ( U.S. NIH Grant/Contract )
First Submitted: May 22, 2013
First Posted: May 27, 2013
Last Update Posted: February 8, 2017
Last Verified: February 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of Florida:
Premature Infant
Nutrition
Enteral